Evidence map›Paper›PMID 36093730›Full record

ArticleThe journal of applied laboratory medicine2022

2021 Patient Preferences for Point of Care Testing Survey: More Acceptance and Less Concern.

Craig M Lilly, Ziyue Wang, Denise Dunlap, Jeffrey Kaye, Sarah Gohtard, Sean Teebagy, Nathaniel Hafer, Eugene J Rogers, Bryan Buchholz, David McManus

Abstract read
In one paragraph

Article in The journal of applied laboratory medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Point-of-care testing preferences 2020-2022: Trends over the years.Cardiovascular digital health journal · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Craig M LillyDepartments of Medicine, Worcester, MA, USA.
Ziyue WangUMass Chan School of Medicine, Worcester, MA, USA.
Denise DunlapUniversity of Massachusetts Lowell, Lowell, MA, USA.
Jeffrey KayeDepartment of Neurology and Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Sarah GohtardDepartment of Neurology and Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.
Sean TeebagyUMass Chan School of Medicine, Worcester, MA, USA.
Nathaniel HaferGraduate School of Biomedical Sciences, Worcester, MA, USA.
Eugene J RogersUniversity of Massachusetts Lowell, Lowell, MA, USA.
Bryan BuchholzUniversity of Massachusetts Lowell, Lowell, MA, USA.
David McManusDepartments of Medicine, Worcester, MA, USA.

Funding

The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep DiseasesU54HL143541 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Apurv Soni · 2018 to 2026
$141.0M
DETECT-AD: Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer's DiseaseR56AG074321 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KAYE, JEFFREY A · 2021 to 2022
$3.5M
NHLBI NIH HHS U54 HL143541NIA NIH HHS R56 AG074321
6 · The paper itself

Abstract

backgroundThe evolving opinions of our community members provide insights into how end-users perceive the value and identify key point-of-care test (POCT) characteristics.

methodsWe deployed our validated 45-item English-language survey to uncompensated volunteers and compared the results from 1264 respondents in 2021 with those obtained in 2020.

resultsAverage responses for items regarding the benefits of POCTs demonstrated that the 2021 respondents indicated agreement with all 14 potential benefits. Average responses for items regarding concerns were distinctly different from those for benefits. The only concern item that scored in the agree range was "not having insurance coverage for POCTs." Average responses to the other 13 concern items were in the disagree range. For 8 of these items, the magnitude of disagreement was greater in the 2021 survey than was observed for the 2020 survey. Differences in POCT exposure over time and by US regions suggest that higher levels of exposure to POCTs in the East are associated with stronger public support.

conclusionsCommunity members strongly support the development of accurate, convenient, easy-to-use, affordable, equitably available, in-home POCTs that produce immediate results. This empowers patients and home caregivers to diagnose, manage, enhance their adherence to medical treatments, and more efficiently engage their physicians.

Indexed as

Patient PreferencePhysiciansHumansPoint-of-Care TestingSurveys and Questionnaireslaboratory testingmedical devicespoint of care technologies

Identifiers

PMID36093730
PMCPMC10641840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.